230 related articles for article (PubMed ID: 22334636)
1. The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases.
Wang M; Mou C; Jiang M; Han L; Fan S; Huan C; Qu X; Han T; Qu Y; Xu G
Eur J Endocrinol; 2012 May; 166(5):797-802. PubMed ID: 22334636
[TBL] [Abstract][Full Text] [Related]
2. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
Huan C; Cui G; Ren Z
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
[TBL] [Abstract][Full Text] [Related]
3. Role of Ki-67 in acromegalic patients with hyperprolactinemia: retrospective analysis in 61 Chinese Patients.
Huan C; Cui G; Lu C; Qu X; Han T
Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):719-23. PubMed ID: 25796164
[TBL] [Abstract][Full Text] [Related]
4. A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin.
De Marinis L; Zuppi P; Valle D; Mancini A; Bianchi A; Lauriola L; Pasquini P; Anile C; Maira G; Giustina A
Horm Metab Res; 2002 Mar; 34(3):137-43. PubMed ID: 11972303
[TBL] [Abstract][Full Text] [Related]
5. Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly.
Kim EH; Oh MC; Lee EJ; Kim SH
Neurosurgery; 2012 May; 70(5):1106-13; discussion 1113. PubMed ID: 22067418
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenomas in acromegalic patients: an immunohistochemical and endocrinological study with special reference to prolactin-secreting adenoma.
Kanie N; Kageyama N; Kuwayama A; Nakane T; Watanabe M; Kawaoi A
J Clin Endocrinol Metab; 1983 Dec; 57(6):1093-101. PubMed ID: 6415083
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Management of Cosecreting Thyroid Stimulating Hormone or Prolactin Pituitary Growth Hormone Adenomas: A Case-Control Study.
Mo C; Chen H; Xu J; Guo Y; Wang Y; Li Z; Tong T; Gui S; Zhong L
Endocr Pract; 2024 May; 30(5):441-449. PubMed ID: 38307455
[TBL] [Abstract][Full Text] [Related]
11. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
Nyquist P; Laws ER; Elliott E
Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
[TBL] [Abstract][Full Text] [Related]
12. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
[TBL] [Abstract][Full Text] [Related]
13. In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells.
Cuny T; Zeiller C; Bidlingmaier M; Défilles C; Roche C; Blanchard MP; Theodoropoulou M; Graillon T; Pertuit M; Figarella-Branger D; Enjalbert A; Brue T; Barlier A
Endocr Relat Cancer; 2016 Jul; 23(7):509-19. PubMed ID: 27267119
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
[TBL] [Abstract][Full Text] [Related]
16. Reoperation for growth hormone-secreting pituitary adenomas: report on an endonasal endoscopic series with a systematic review and meta-analysis of the literature.
Almeida JP; Ruiz-Treviño AS; Liang B; Omay SB; Shetty SR; Chen YN; Anand VK; Grover K; Christos P; Schwartz TH
J Neurosurg; 2018 Aug; 129(2):404-416. PubMed ID: 28862548
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas.
Hofstetter CP; Mannaa RH; Mubita L; Anand VK; Kennedy JW; Dehdashti AR; Schwartz TH
Neurosurg Focus; 2010 Oct; 29(4):E6. PubMed ID: 20887131
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone and prolactin in tissue culture of pituitary adenoma.
Demura R; Kubo O; Odagiri E; Nomura K; Yamaguchi H
Endocrinol Jpn; 1977 Jun; 24(3):259-64. PubMed ID: 913336
[TBL] [Abstract][Full Text] [Related]
19. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
Chang CC; Chen FW; Hsieh HC
Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]